Summary
We have studied the influence of food and dose (50, 100, 200 mg) on the oral systemic availability of the broad spectrum antifungal itraconazole and the pharmacokinetics after repeated dosing of 100 mg in six healthy volunteers.
The relative systemic availability of itraconazole capsules compared with solution averaged 39.8% in the fasting state but 102% in the post-prandial state. Food did not significantly affect the tmax of the capsules. Itraconazole AUC at single doses of 50, 100, and 200 mg had a ratio of 0.3:1:2.7, and the steady-state AUC (0–24) after 15 days of 100 mg was five times the single-dose AUC.
These findings suggest non-linear itraconazole pharmacokinetics in the range of therapeutically used doses. Furthermore, capsules should be given shortly after a meal to ensure optimal oral systemic availability.
References
Van Cutsem J, Van Gerven F, Janssen PAJ (1987) Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 9: S15-S32
Cauwenbergh G (1987) Itraconazole: The first orally active antifungal for single-day treatment of vaginal candidosis. Curr Ther Res 41: 210–214
Delescluse J, Cauwenbergh G, Degreef H (1986) Itraconazole, a new orally active antifungal, in the treatment of pityriasis verscolor. Br J Dermatol 114: 701–703
Woestenborghs R, Lorreyne W, Heykants J (1987) Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr Biomed Appl 413: 332–337
SAS User's Guide (1985) SAS Institute, Cary
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Peer, A., Woestenborghs, R., Heykants, J. et al. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur J Clin Pharmacol 36, 423–426 (1989). https://doi.org/10.1007/BF00558308
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558308